Six Myths About Serialisation
The countdown on adherence to global serialisation is well underway.
Early adopters, such as Turkey and Argentina, required serialisation as early as 2010 and were followed by others such as India, China and Korea.
Over the next three years, many other major markets will require adherence to their own serialisation requirements, including the United States and the European Union.
In 2018, serialisation mandates will govern most of the world’s drug supply.
Biopharmaceutical companies that don’t comply will find it impossible to market their drugs in countries that have instituted serialisation regulations.
To find out more, download the paper for free.
Download to find out more.